IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

Indian Pharma Network (IPN)

Medicines For Esophageal Cancer Treatment

IPN, New Delhi can facilitate Esophageal cancer patient to “import of  Medicines For Esophageal Cancer Treatment” for personal use under “patient name basis” treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

Indian Pharma Network

M: +91-9891296838 / 9811747774
E:  med@indianpharmanetwork.co.in

Esophageal Cancer Treatment

Esophageal cancer is a type of cancer that occurs in the esophagus, which is the muscular tube that connects the throat to the stomach. The esophagus plays an important role in the process of swallowing, and it moves food and liquids from the mouth to the stomach. There are two main types of esophageal cancer: squamous cell carcinoma and adenocarcinoma. Squamous cell carcinoma typically starts in the upper part of the esophagus, while adenocarcinoma often occurs in the lower part of the esophagus near the stomach.

Diagnosis of esophageal cancer typically involves an endoscopy, which is a procedure that allows doctors to examine the esophagus using a flexible tube with a camera. Other tests may include imaging tests such as CT or PET scans.

Treatment options for esophageal cancer may include surgery, chemotherapy, radiation therapy, immunotherapy, or a combination of these approaches. The choice of treatment will depend on the stage and location of the cancer, as well as the patient’s overall health and individual preferences.

 

Get Access FDA Approved Medicines For Esophageal Cancer Treatment

Chemotherapy is often used in combination with radiation therapy and/or surgery for the treatment of esophageal cancer. The specific chemotherapy medications used may vary depending on the stage and type of the cancer. Here are some examples of chemotherapy medications that may be used to treat esophageal cancer:

  • Cisplatin:
    Cisplatin is a chemotherapy medication that is often used in combination with 5-fluorouracil (5-FU) for the treatment of esophageal cancer. It works by preventing cancer cells from dividing and growing.
  • 5-fluorouracil (5-FU):
    5-FU is a chemotherapy medication that is often used in combination with cisplatin for the treatment of esophageal cancer. It works by preventing cancer cells from dividing and growing.
  • Paclitaxel:
    Paclitaxel is a chemotherapy medication that may be used in combination with cisplatin for the treatment of esophageal cancer. It works by preventing cancer cells from dividing and growing.
  • Carboplatin: Carboplatin is a chemotherapy medication that may be used in combination with paclitaxel for the treatment of esophageal cancer. It works by preventing cancer cells from dividing and growing.
  • Docetaxel:
    Docetaxel is a chemotherapy medication that may be used alone or in combination with other chemotherapy drugs for the treatment of esophageal cancer. It works by preventing cancer cells from dividing and growing.

It’s important to note that the use of chemotherapy in the treatment of esophageal cancer is highly individualized, and the specific medications and treatment plan will depend on the stage and type of the cancer, as well as the individual patient’s needs. A healthcare provider will determine the most appropriate treatment plan for each patient.

Targeted therapy medications are a type of cancer treatment that targets specific molecules involved in the growth and spread of cancer cells. They are often used in combination with chemotherapy and/or radiation therapy for the treatment of esophageal cancer. Here are some examples of targeted therapy medications that may be used to treat esophageal cancer:

  • Trastuzumab:
    Trastuzumab is a targeted therapy medication that targets the HER2 protein. It may be used in combination with chemotherapy for the treatment of HER2-positive esophageal cancer.
  • Ramucirumab:
    Ramucirumab is a targeted therapy medication that targets the VEGFR-2 protein. It may be used in combination with chemotherapy for the treatment of advanced esophageal cancer.
  • Pembrolizumab:
    Pembrolizumab is an immunotherapy medication that targets the PD-1 protein. It may be used for the treatment of advanced esophageal cancer that has tested positive for the PD-L1 protein.
  • Nivolumab:
    Nivolumab is an immunotherapy medication that targets the PD-1 protein. It may be used for the treatment of advanced esophageal cancer that has tested positive for the PD-L1 protein.

It’s important to note that the use of targeted therapy medications in the treatment of esophageal cancer is highly individualized, and the specific medications and treatment plan will depend on the stage and type of the cancer, as well as the individual patient’s needs. A healthcare provider will determine the most appropriate treatment plan for each patient.

Immunotherapy is a type of cancer treatment that works by helping the body’s immune system to recognize and attack cancer cells. Here are some examples of immunotherapy medications that may be used to treat esophageal cancer:

  • Pembrolizumab:
    Pembrolizumab is a checkpoint inhibitor medication that targets the PD-1 protein. It may be used for the treatment of advanced esophageal cancer that has tested positive for the PD-L1 protein.
  • Nivolumab: Nivolumab is a checkpoint inhibitor medication that targets the PD-1 protein. It may be used for the treatment of advanced esophageal cancer that has tested positive for the PD-L1 protein.
  • Durvalumab:
    Durvalumab is a checkpoint inhibitor medication that targets the PD-L1 protein. It may be used in combination with chemotherapy for the treatment of advanced esophageal cancer.
  • Atezolizumab:
    Atezolizumab is a checkpoint inhibitor medication that targets the PD-L1 protein. It may be used in combination with chemotherapy for the treatment of advanced esophageal cancer.
  • Ipilimumab:
    Ipilimumab is an immunotherapy medication that targets the CTLA-4 protein. It may be used in combination with nivolumab for the treatment of advanced esophageal cancer.

It’s important to note that the use of immunotherapy medications in the treatment of esophageal cancer is highly individualized, and the specific medications and treatment plan will depend on the stage and type of the cancer, as well as the individual patient’s needs. A healthcare provider will determine the most appropriate treatment plan for each patient.

 

Radiation therapy uses high-energy radiation to kill cancer cells. It may be used before or after surgery, or in combination with chemotherapy. Radiation therapy can help to shrink tumors and relieve symptoms of esophageal cancer.

It’s important to note that treatment plans for esophageal cancer are highly individualized, and the medications and treatments used will depend on the stage and location of the cancer, as well as the overall health of the patient. It’s best to consult with an oncologist to determine the most appropriate treatment plan for your specific case.

Legitimate Healthcare Consultant and Facilitator In Delhi

If you have a question relating to anti-cancer medicines approved for treatment of Esophageal Cancer, a problem which you do not know how to resolve it, or concrete inquiry – we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in  as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398